Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/01/2007US20070254945 Aminocyclohexyl ether compounds and uses thereof
11/01/2007US20070254944 Metformin and a dipeptidyl peptidase IV inhibitor such as vildagliptin; improving glucose control
11/01/2007US20070254943 pulmonary disorders; bronchodilators; 2-[(S)-1-{2-[4-(2-Ethylaminoethyl)phenyl]ethyl}pyrrolidin-3-yl]-2,2-diphenylacetamide
11/01/2007US20070254942 1S)-Cyclopropanecarboxylic acid {7-chloro-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}amide, which may further contain an anticancer agent or an antiinflammatory agent; treating atopic dermatitis, Crohn's disease, and colon cancer
11/01/2007US20070254941 Subtantially pure ropinirole hydrochloride, polymorphic form of ropinirole and process for their preparation
11/01/2007US20070254940 1,5 And 3,6- substituted indole compounds having NOS inhibitory activity
11/01/2007US20070254939 Formulations Containing Amide Derivatives of Carboxylic Acid NSAIDS for Topical Administration to the Eye
11/01/2007US20070254938 Preventive or Therapeutic Agent for Vascular Intimal Proliferative Disease
11/01/2007US20070254937 Thienopyrazoles
11/01/2007US20070254935 Pyrazole and imidazole compounds and uses thereof
11/01/2007US20070254934 Antiviral drugs for treatment of arenavirus infection
11/01/2007US20070254933 Use against hormone refractory prostate cancer; 1-(3-trifluoromethyl-4-cyanophenyl)-2-thioxo-3-(substituted phenyl)-imidazolidin-5-one and spiro ring derivatives thereof; selective androgen receptor modulators; non-steroidal, non-toxic, and tissue selective
11/01/2007US20070254932 Drugs for Treating Duplication of Hypertension With Hyperuricemia and/or Hypercholesterolemia
11/01/2007US20070254931 Thiazole Derivatives Having Vap-1 Inhibitory Activity
11/01/2007US20070254930 Osteoporosis drug N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl) phenoxy]pentoxy}-benzamidine (DW-1350) and an alkali metal carbonate, an alkali metal bicarbonate, or an alkaline earth metal carbonate
11/01/2007US20070254929 Fluoro-and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
11/01/2007US20070254928 Use of Roflumilast for the Prophylaxis or Treatment of Emphysema
11/01/2007US20070254926 Pyridylphenyl compounds for inflammation and immune-related uses
11/01/2007US20070254925 Thiazole and thiadiazole compounds for inflammation and immune-related uses
11/01/2007US20070254924 Salts of benzimidazole compound and use thereof
11/01/2007US20070254923 Therapeutic salt compositions and methods
11/01/2007US20070254922 Computer system and control method for the computer system
11/01/2007US20070254921 Reducing activity of mutant of human cytochrome enzyme; Administering to individual in need of nicotine replacement therapy therapeutically effective amount of nicotine and methoxsalen, to enhance effectiveness
11/01/2007US20070254920 Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
11/01/2007US20070254919 Aroyl-O-Piperidine Derivatives for the Treatment of Diabetes-Related Problems
11/01/2007US20070254918 Dopamine-, Norepinephrine- and Serotonin- Transporter-Selective Heterocyclic Compounds and Their Therapeutic Applications
11/01/2007US20070254917 Intracellular receptor modulator compounds and methods
11/01/2007US20070254916 Aryl and heteroaryl compounds, compositions, and methods of use
11/01/2007US20070254915 Cxcr4 modulators
11/01/2007US20070254914 Low-concentration atropine solution for preventing myopia progression and preparing method thereof
11/01/2007US20070254913 3-Ethyl-6-(1-ethyl-1H-pyrazol-5-yl)-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridine; adenosine monophosphate activator; antiinflammatory agent, antidepressant, antiallergen, cognition activator, neurodegenerative diseases; arthritis, Alzheimer's disease, schizophrenia, Parkinson disease
11/01/2007US20070254912 Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
11/01/2007US20070254911 Tetrahydro-Pyrazolo[3,4-c]Pyridine Cannabinoid Modulators
11/01/2007US20070254910 Chemokine receptor; antiinflammatory agents; anticancer agents; antiarthritic agents
11/01/2007US20070254909 Novel Pyridine Derivatives, a Process for Their Preparation and a Pharmaceutical Composition Containing the Same
11/01/2007US20070254908 7-azaindoles, pharmaceutical compositions and their therapeutic applications
11/01/2007US20070254906 Method of Administration of Dopamine Receptor Agonists
11/01/2007US20070254905 Pharmaceutical Formulation for Increasing Solubility of 10-Hydroxycamptothecin Compounds in Non-Aqueous Polar Solvents
11/01/2007US20070254904 schizophrenia, emesis, anxiety and depression, irritable bowel syndrome (IBS), circadian rhythm disturbances, pre-eclampsia, nociception, neuropathic pain, pancreatitis, neurogenic inflammation, asthma, chronic obstructive pulmonary disease (COPD) and urinary incontinence
11/01/2007US20070254903 Novel Spiroindoline or Spiroisoquinoline Compounds, Methods of Use and Compositions Thereof
11/01/2007US20070254902 Methods and compositions utilizing quinazolinones
11/01/2007US20070254901 Cancer; 2-(methylthio)-6-phenyl-7-(4-{[4-(5-pyridin-2-yl-4H-1,2,4-triazol-3-yl)piperidin-1-yl]methyl}phenyl)pyrido[2,3-d]pyrimidine;serine/threonine kinase (Akt) suppression; increased cellular potency or solubility, greater selectivity, enhanced pharmacokinetic properties, lack of off target activity
11/01/2007US20070254900 Treatments for Congestive Heart Failure
11/01/2007US20070254899 Soluble salts of thieno[2,3-d]pyrimidine derivatives
11/01/2007US20070254898 Thienopyrimidine and Thienopyridine Derivatives Substituted with Cyclic Amino Group
11/01/2007US20070254897 Compositions and methods for the treatment of cardiovascular disease
11/01/2007US20070254896 Substituted pyrimidine kinase inhibitors
11/01/2007US20070254895 Crystalline solvate of glucokinase activator
11/01/2007US20070254894 Novel small molecules with selective cytotoxicity against human microvascular endothelial cell proliferation
11/01/2007US20070254893 Combination Product Comprising Src Kinase Inhibitor Azdo530 and an Antioestrogen or Egfr-Tk-Inhibitor
11/01/2007US20070254892 Dihydropyrazolopyrimidinone derivatives
11/01/2007US20070254891 Crystalline forms of 4-(2-fluorophenyl)-6-methyl-2-(piperazin-1-yl)thieno[2,3-d]pyrimidine
11/01/2007US20070254890 4(Phenyl-Piperazinyl-Methyl) Benzamide Derivatives and Their Use for the Treatment of Pain or Gastrointestinal Disorders
11/01/2007US20070254889 noninvasive technique for imaging and quantitating amyloid deposits; 2-phenyl- imidazo [1,2,a] pyridine derivatives; radiolabelling; drug delivery; 2-(4'-dimethylaminophenyl)-6-iodobenzothiazole
11/01/2007US20070254888 Piperazinediones as Oxytocin Receptor Antagonists
11/01/2007US20070254887 Pharmaceutical Composition for Transdermal Administration of Perospirone
11/01/2007US20070254886 N-[5-bromo-3-({3-[2-(dimethylamino)ethoxy]-4-methoxybenzyl}oxy)pyridin-2-yl]-4-methylbenzenesulfonamide, used for prevention and/or treatment of infections, inflammatory and/or allergic diseases
11/01/2007US20070254885 Use of type V phosphodiesterase inhibitors in the treatment of exercise induced pulmonary hemorrhage in the equine
11/01/2007US20070254884 Compositions and Methods for Inducing Cell Dedifferentiation
11/01/2007US20070254883 3-cyclobutyl-1-[(4-phenoxyphenyl)ethynyl]imidazo[1,5-a]pyrazin-8-amine, N-{3-[(8-amino-3-cyclobutylimidazo[1,5-a]pyrazin-1-yl)ethynyl]phenyl}-4-chlorobenzamide; inhibitors of mammalian Target Of Rapamycin (mTOR) kinase; cancer
11/01/2007US20070254882 Sulfamide Derivatives and Pharmaceutical Composition for Upregulation of Lipid Metabolism Comprising Same
11/01/2007US20070254881 Pyrazole Derivative
11/01/2007US20070254880 Heteroaryl Piperidine Glycine Transporter Inhibitors
11/01/2007US20070254879 Inhibitors of checkpoint kinases
11/01/2007US20070254878 Administering 1,2,3,6-tetrasubstituted pyrido[3,4-b]indoles to inhibit the 5'-untranslated region-dependent translation; angiogenesis inhibitors; anticarcinogenic agents; retinopathy, rheumatoid arthritis, psoriasis, atherosclerosis, obesity, macular degeneration; may cause hypertension or proteinurea
11/01/2007US20070254877 Indole Derivative and Use for Treatment of Cancer
11/01/2007US20070254876 Glucuronate salt of a piperazine compound
11/01/2007US20070254875 Androgen Receptor Modulator Compounds and Methods
11/01/2007US20070254874 gastrointestinal disorders, urinary tract disorders such as hyperactive bladder, and cardiovascular disorders without side effects related to CNS activity; acid moiety makes drug unable to cross the blood-brain barrier; carboxy, phosphonic, sulfonic, or phosphoric acid derivative of piboserod (DDL-6001)
11/01/2007US20070254873 Chemical Compounds
11/01/2007US20070254872 Antibacterial Agents
11/01/2007US20070254871 Compounds for the Treatment of Inflammation of the Central Nervous System
11/01/2007US20070254870 3-Benzyl-7-chloro-2-[2-methyl-1-(7-oxo-[1,4]diazepan-1-yl)-propyl]-3H-quinazolin-4-one; mitotic kinesin KSP inhibitors; dysfunction of mitotic spindle, resulting in cell cycle arrest and cell death; anticarcinogenic, antiinflammatory, antiproliferative agents
11/01/2007US20070254869 modulators of Cholesterol ester transfer protein activity, such as 5-[Acetyl-(3,5-bis-trifluoromethyl-benzyl)-amino]-7-trifluoromethyl-2,3,4,5-tetrahydro-benzo[b]azepine-1-carboxylic acid isopropyl ester, for treating or preventing cardiovascular disorders
11/01/2007US20070254868 such as 3-(1-(2,3-difluorophenyl)-1H-tetrazol-5-yl)-5-(4-(4-methylpiperazin-1-yl) phenyl)pyridin-2-amine, used as anticarcinogenic agents or for the treatment of atherosclerosis and lung fibrosis
11/01/2007US20070254867 Heterocyclic Kinase Inhibitors
11/01/2007US20070254866 Aminoquinolones as GSK-3 inhibitors
11/01/2007US20070254865 Aminocyclohexanes as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
11/01/2007US20070254864 Chromium complexes
11/01/2007US20070254863 Use of CBx cannabinoid receptor modulators as potassium channel modulators
11/01/2007US20070254862 Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators
11/01/2007US20070254861 Methods for the prevention and/or treatment of peripheral arterial disease
11/01/2007US20070254860 15 Beta-Substituted Steroids Having Selective Estrogenic Activity
11/01/2007US20070254859 Compounds exhibiting efflux inhibitor activity and composition and uses thereof
11/01/2007US20070254858 Contraceptive and Acne Medication Combination and Treatment of Acne and Other Diseases with Reduced Side Effects
11/01/2007US20070254857 2Alpha-Methyl-19-Nor-(20S)-1Alpha-Hydroxy-Bishomopregnacalciferol and Its Uses
11/01/2007US20070254856 Use of acetylsalicylic acid (ASA) in the application of a membrane lung
11/01/2007US20070254855 Method for the treatment of acne
11/01/2007US20070254854 Aqueous Antiseptic Solution and Compatible Anionic Dye for Staining Skin
11/01/2007US20070254853 Compositions and Methods for Promotion of Wound Healing
11/01/2007US20070254852 for treatment of cancer
11/01/2007US20070254851 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
11/01/2007US20070254850 Methods for Treating and Preventing Apoptosis-Related Diseases Using Rna Interfering Agents
11/01/2007US20070254849 Ryanodine receptor inhibitors and methods relating thereto
11/01/2007US20070254848 Algin Oligosaccharides and the Derivatives thereof as Well as the Manufacture and the Use of the Same
11/01/2007US20070254847 Pharmaceutical Composition Containing Steroidal Saponins, the Preparation Method and Use Thereof
11/01/2007US20070254843 Methods for treating bone associated diseases by the use of methionine aminopeptidase-2 inhibitors
11/01/2007US20070254841 Formulations and methods for treating dry eye
11/01/2007US20070254839 Orally administered peptides synergize statin activity
11/01/2007US20070254837 Treatment for Necrotizing Enterocolitis
1 ... 3520 3521 3522 3523 3524 3525 3526 3527 3528 3529 3530 3531 3532 3533 3534 3535 3536 3537 3538 3539 3540 ... 7860